BDRX: Biodexa Pharmaceuticals Plc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Armistice Capital, LLC | 9.99% | SEC |
Institutional ownership (Q2 2026)
7 institutions reported holding $48K of Biodexa Pharmaceuticals Plc on Form 13F (1 the quarter before). 5 opened a new position and 0 sold out. Shares held by institutions: +10871%.
| Largest holders | Shares | Value |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 14,809 | $43K |
| GAMMA Investing LLC | 1,203 | $4K |
| Allied Private Wealth LLC | 489 | $1K |
| SBI Securities Co., Ltd. | 29 | $84 |
| UBS Group AG | 25 | $73 |
| Hilton Head Capital Partners, LLC | 6 | $17 |
| Caitong International Asset Management Co., Ltd | 5 | $15 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.